FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1717720907> ?p ?o ?g. }

• W1717720907 endingPage "156" @default.
• W1717720907 startingPage "147" @default.
• W1717720907 abstract "Albertsson P, Lennernäs B, Norrby K. Low-dosage metronomic chemotherapy and angiogenesis: topoisomerase inhibitors irinotecan and mitoxantrone stimulate VEGF-A-mediated angiogenesis. APMIS 2011. Metronomic chemotherapy with cytotoxic agents has been shown to inhibit angiogenesis and, consequently, tumor growth by targeting vascular endothelial cells (ECs). In these regimens, anti-tumor activities additional to anti-angiogenesis may operate. Moreover, chemotherapy typically generates reactive oxygen species in targeted ECs, which can affect angiogenesis. The aim of the present study was to assess the systemic effect of low-dosage metronomic treatment with either irinotecan or mitoxantrone on angiogenesis induced by VEGF-A. Angiogenesis was induced in normal adult rat mesentery by intraperitoneal injection of a low dosage of VEGF-A. Thereafter, irinotecan and mitoxantrone were infused separately continuously at minimally toxic dosages for 14 consecutive days via a subcutaneous osmotic minipump. Angiogenesis was assessed in terms of objective and quantitative variables using morphologic and computerized image analyses. Irinotecan or mitoxantrone significantly stimulated angiogenesis, with ironotecan increasing angiogenesis by 104%, when compared with the vehicle-treated animals. Low-dosage metronomic chemotherapy with irinotecan or mitoxantrone stimulates angiogenesis in the normal mesentery of rats, probably by inducing low-level oxidative stress in the targeted ECs. Whether or not this pertains to tumor angiogenesis may be difficult to confirm, as several anti-tumor modes may operate during low-dosage metronomic chemotherapy." @default.
• W1717720907 created "2016-06-24" @default.
• W1717720907 creator A5001741144 @default.
• W1717720907 creator A5080248529 @default.
• W1717720907 creator A5088137780 @default.
• W1717720907 date "2011-10-25" @default.
• W1717720907 modified "2023-09-26" @default.
• W1717720907 title "Low‐dosage metronomic chemotherapy and angiogenesis: topoisomerase inhibitors irinotecan and mitoxantrone stimulate VEGF‐A‐mediated angiogenesis" @default.
• W1717720907 cites W1481770206 @default.
• W1717720907 cites W1598379886 @default.
• W1717720907 cites W1968354884 @default.
• W1717720907 cites W1968967017 @default.
• W1717720907 cites W1971646880 @default.
• W1717720907 cites W1972187137 @default.
• W1717720907 cites W1973091654 @default.
• W1717720907 cites W1978761195 @default.
• W1717720907 cites W1980499827 @default.
• W1717720907 cites W1980791390 @default.
• W1717720907 cites W1981777416 @default.
• W1717720907 cites W1982159082 @default.
• W1717720907 cites W1984750597 @default.
• W1717720907 cites W1997062281 @default.
• W1717720907 cites W1998792312 @default.
• W1717720907 cites W2001498331 @default.
• W1717720907 cites W2002394942 @default.
• W1717720907 cites W2011077759 @default.
• W1717720907 cites W2013492504 @default.
• W1717720907 cites W2018929154 @default.
• W1717720907 cites W2025630052 @default.
• W1717720907 cites W2027015392 @default.
• W1717720907 cites W2027851837 @default.
• W1717720907 cites W2029883816 @default.
• W1717720907 cites W2032101943 @default.
• W1717720907 cites W2032783392 @default.
• W1717720907 cites W2033284441 @default.
• W1717720907 cites W2038475449 @default.
• W1717720907 cites W2040179925 @default.
• W1717720907 cites W2062036842 @default.
• W1717720907 cites W2062991201 @default.
• W1717720907 cites W2067506841 @default.
• W1717720907 cites W2073359472 @default.
• W1717720907 cites W2077501711 @default.
• W1717720907 cites W2079195634 @default.
• W1717720907 cites W2081579609 @default.
• W1717720907 cites W2098122003 @default.
• W1717720907 cites W2101697273 @default.
• W1717720907 cites W2102392974 @default.
• W1717720907 cites W2106925175 @default.
• W1717720907 cites W2115785123 @default.
• W1717720907 cites W2117013761 @default.
• W1717720907 cites W2137268781 @default.
• W1717720907 cites W2147711740 @default.
• W1717720907 cites W2152216185 @default.
• W1717720907 cites W2154736427 @default.
• W1717720907 cites W2155036200 @default.
• W1717720907 cites W2159127121 @default.
• W1717720907 cites W2159789252 @default.
• W1717720907 cites W2163087283 @default.
• W1717720907 cites W3080506109 @default.
• W1717720907 doi "https://doi.org/10.1111/j.1600-0463.2011.02830.x" @default.
• W1717720907 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3321228" @default.
• W1717720907 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22229270" @default.
• W1717720907 hasPublicationYear "2011" @default.
• W1717720907 type Work @default.
• W1717720907 sameAs 1717720907 @default.
• W1717720907 citedByCount "11" @default.
• W1717720907 countsByYear W17177209072012 @default.
• W1717720907 countsByYear W17177209072013 @default.
• W1717720907 countsByYear W17177209072014 @default.
• W1717720907 countsByYear W17177209072015 @default.
• W1717720907 countsByYear W17177209072016 @default.
• W1717720907 countsByYear W17177209072023 @default.
• W1717720907 crossrefType "journal-article" @default.
• W1717720907 hasAuthorship W1717720907A5001741144 @default.
• W1717720907 hasAuthorship W1717720907A5080248529 @default.
• W1717720907 hasAuthorship W1717720907A5088137780 @default.
• W1717720907 hasBestOaLocation W17177209071 @default.
• W1717720907 hasConcept C121608353 @default.
• W1717720907 hasConcept C126322002 @default.
• W1717720907 hasConcept C147897179 @default.
• W1717720907 hasConcept C202751555 @default.
• W1717720907 hasConcept C2776694085 @default.
• W1717720907 hasConcept C2779682216 @default.
• W1717720907 hasConcept C2780259306 @default.
• W1717720907 hasConcept C2780394083 @default.
• W1717720907 hasConcept C2780923524 @default.
• W1717720907 hasConcept C502942594 @default.
• W1717720907 hasConcept C526805850 @default.
• W1717720907 hasConcept C55493867 @default.
• W1717720907 hasConcept C71924100 @default.
• W1717720907 hasConcept C86803240 @default.
• W1717720907 hasConcept C98274493 @default.
• W1717720907 hasConceptScore W1717720907C121608353 @default.
• W1717720907 hasConceptScore W1717720907C126322002 @default.
• W1717720907 hasConceptScore W1717720907C147897179 @default.
• W1717720907 hasConceptScore W1717720907C202751555 @default.
• W1717720907 hasConceptScore W1717720907C2776694085 @default.
• W1717720907 hasConceptScore W1717720907C2779682216 @default.

• next